← Browse by Condition
Medical Condition

hematopoietic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06261060 Phase 2
Recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Enrollment
6 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →